SGS bolsters E&L testing capabilities at Shanghai laboratory
SGS has increased its extractables and leachables (E&L) testing capabilities at its Shanghai, China-based laboratory.
SGS has increased its extractables and leachables (E&L) testing capabilities at its Shanghai, China-based laboratory.
Parexel and Sanofi have launched a pilot study that will examine the use of remote data collection devices in clinical trials.
LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.
update
Bristol Myers Squibb (B-MS) says the lot of Eliquis recalled in the US this week was made by AstraZeneca’s contract manufacturing business.
Update with comment from MHRA
The European Commission has confirmed that UK drug ingredient manufacturers will have to supply European customers with written confirmation their products are made in compliance with EU standards after Brexit.
Inovio Pharmaceuticals has started Phase III trials of its DNA-based human papillomavirus therapy VGX-3100 after the US FDA lifted a clinical hold imposed list year.